• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
IMU

IMUGENE LIMITED - Announcements

0.94% ! 26.8¢
Market Cap $77.17M  !

Imugene Limited is a clinical-stage immune-oncology company. It is engaged in developing... Imugene Limited is a clinical-stage immune-oncology company. It is engaged in developing a range of new and novel immunotherapies that seek to activate the immune system of cancer patients to treat and eradicate tumors. Its platform technology seeks to harness and promote the body’s immune system against cancerous tumors. Its product pipeline includes an off-the-shelf (allogeneic) cell therapy CAR T drug Azer-Cel (azercabtagene zapreleucel) which targets CD19 to attack blood cancer. Its pipeline includes an Oncolytic Virus and B-Cell Immunotherapies aimed at treating a variety of cancers in combination with standard of care drugs and immunotherapies. Its lead candidate is a chimeric vaccinia (pox) virus known as CF33, which is a combination of genomic sequences from multiple vaccinia virus strains to generate a new, safer and more potent virus. Its Chimeric antigen receptor (CAR)-engineered T cells (CAR T) are T cells redirected against tumors through engineered expression of CARs. More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Announcements



Filters [Clear]
  • Price Sensitive: Yes
IMU Appendix 4C - Quarterly and Business UpdatePRICE SENSITIVE16/04/19 download Created with Sketch. 270.77KB
IMU IMU presents new mimotope PD-1 vaccine data at AACRPRICE SENSITIVE03/04/19 download Created with Sketch. 160.49KB
IMU IMU presents new KEY-Vaxx and B-Vaxx data at AACRPRICE SENSITIVE02/04/19 download Created with Sketch. 164.88KB
IMU IMU presents positive new HER-Vaxx data at AACRPRICE SENSITIVE02/04/19 download Created with Sketch. 167.49KB
IMU IMU Pre-IND FDA Meeting Provides Guidance for KEY-VaxxPRICE SENSITIVE20/03/19 download Created with Sketch. 75.86KB
IMU Imugene doses first patient in HER-Vaxx phase 2 trialPRICE SENSITIVE14/03/19 download Created with Sketch. 96.99KB
IMU IMU Announces Presentations on KEY-Vaxx and B-Vaxx at AACRPRICE SENSITIVE04/03/19 download Created with Sketch. 100.39KB
IMU Half Yearly Report and AccountsPRICE SENSITIVE28/02/19 download Created with Sketch. 4.58MB
IMU Pause in TradingPRICE SENSITIVE28/02/19 download Created with Sketch. 116KB
IMU Imugene Announces Presentation on HER-Vaxx at the AACR 2019PRICE SENSITIVE28/02/19 download Created with Sketch. 85.19KB
IMU Appendix 4C - Quarterly and Business UpdatePRICE SENSITIVE30/01/19 download Created with Sketch. 557.58KB
IMU Investor PresentationPRICE SENSITIVE10/01/19 download Created with Sketch. 11.83MB
IMU IMU Meets Endpoints in Phase 1b Gastric Cancer TrialPRICE SENSITIVE17/12/18 download Created with Sketch. 114.47KB
IMU Imugene Advances to Phase 2 in Gastric Cancer TrialPRICE SENSITIVE13/11/18 download Created with Sketch. 366.09KB
IMU Imugene Receives $1.85 million R&D Tax IncentivePRICE SENSITIVE09/11/18 download Created with Sketch. 101.15KB
IMU Appendix 4C - quarterlyPRICE SENSITIVE30/10/18 download Created with Sketch. 1.05MB
IMU Imugene commences cGMP manufacture of PD-1 cancer vaccinePRICE SENSITIVE21/09/18 download Created with Sketch. 141.95KB
IMU Imugene Completes Phase 1b Cancer Vaccine Trial RecruitmentPRICE SENSITIVE11/09/18 download Created with Sketch. 393.79KB
IMU Appendix 4E and Audited Financial ReportPRICE SENSITIVE31/08/18 download Created with Sketch. 539.83KB
IMU Appendix 4C - Quarterly and Business UpdatePRICE SENSITIVE31/07/18 download Created with Sketch. 555.82KB
IMU PD-1 cancer vaccine development updatePRICE SENSITIVE23/07/18 download Created with Sketch. 399.17KB
IMU Response to ASX QueryPRICE SENSITIVE08/06/18 download Created with Sketch. 496.2KB
IMU ProspectusPRICE SENSITIVE07/06/18 download Created with Sketch. 976.05KB
IMU IMUGENE RAISES $20.1 MILLIONPRICE SENSITIVE07/06/18 download Created with Sketch. 584.16KB
IMU Imugene Licences Extensive B-Cell Immuno-Oncology PortfolioPRICE SENSITIVE07/06/18 download Created with Sketch. 341.69KB
IMU Trading HaltPRICE SENSITIVE05/06/18 download Created with Sketch. 443.43KB
IMU Appendix 4C - quarterlyPRICE SENSITIVE26/04/18 download Created with Sketch. 658.65KB
IMU Leslie Chong Appointed as Managing DirectorPRICE SENSITIVE28/03/18 download Created with Sketch. 223.16KB
IMU Half Yearly Report and AccountsPRICE SENSITIVE27/02/18 download Created with Sketch. 273.35KB
IMU Arginine Modulator Active in Cancer ModelsPRICE SENSITIVE19/02/18 download Created with Sketch. 242.78KB
IMU Novel Anti-PD-1 Mimotope Vaccine Ready for DevelopmentPRICE SENSITIVE12/02/18 download Created with Sketch. 167.45KB
IMU IMU Meets Investigator for Gastric Cancer Clinical TrialPRICE SENSITIVE09/02/18 download Created with Sketch. 45.28KB
IMU Cancer vaccine shows early promise in clinical trialPRICE SENSITIVE07/02/18 download Created with Sketch. 238.61KB
IMU Business Update - December Quarter Appendix 4CPRICE SENSITIVE29/01/18 download Created with Sketch. 986.49KB
IMU Rights Issue Results & Shortfall NotificationPRICE SENSITIVE19/12/17 download Created with Sketch. 37.68KB
IMU ProspectusPRICE SENSITIVE23/11/17 download Created with Sketch. 946.63KB
IMU IMUGENE RAISES $8.7 MILLIONPRICE SENSITIVE23/11/17 download Created with Sketch. 72.07KB
IMU Trading HaltPRICE SENSITIVE21/11/17 download Created with Sketch. 264.26KB
IMU Appendix 4C - Quarterly and Business UpdatePRICE SENSITIVE27/10/17 download Created with Sketch. 990.52KB
IMU Response to ASX Price QueryPRICE SENSITIVE17/10/17 download Created with Sketch. 609.6KB
IMU IMU Receives $1.1m R&D Tax RefundPRICE SENSITIVE11/10/17 download Created with Sketch. 296.02KB
IMU First Patient Dosing Commences of HER-VaxxPRICE SENSITIVE31/08/17 download Created with Sketch. 53.78KB
IMU Appendix 4E and Annual ReportPRICE SENSITIVE31/08/17 download Created with Sketch. 642.26KB
IMU Appendix 4C - quarterlyPRICE SENSITIVE31/07/17 download Created with Sketch. 984.1KB
IMU Imugene granted Canadian patent for Her-Vaxx cancer vaccinePRICE SENSITIVE21/07/17 download Created with Sketch. 42.21KB
IMU Appendix 4C - quarterly and Commentry Q3PRICE SENSITIVE28/04/17 download Created with Sketch. 856.23KB
IMU IMU Raises $3.0m from Options PlanPRICE SENSITIVE06/04/17 download Created with Sketch. 33.34KB
IMU $1.35 million Options UnderwrittenPRICE SENSITIVE30/03/17 download Created with Sketch. 66.21KB
IMU Half Year Report and AccountsPRICE SENSITIVE28/02/17 download Created with Sketch. 219.56KB
IMU Intellectual Property Strengthened Around Lead Clinical DrugPRICE SENSITIVE27/02/17 download Created with Sketch. 247.31KB
IMU BMC Cancer journal publishes encouraging HER-Vaxx researchPRICE SENSITIVE13/02/17 download Created with Sketch. 243.06KB
IMU Appendix 4C - quarterlyPRICE SENSITIVE27/01/17 download Created with Sketch. 295.18KB
IMU Imugene progresses mimotope platformPRICE SENSITIVE19/12/16 download Created with Sketch. 239.63KB
IMU Response to ASX Aware QueryPRICE SENSITIVE16/12/16 download Created with Sketch. 202.23KB
IMU Response to ASX Price QueryPRICE SENSITIVE13/12/16 download Created with Sketch. 412.71KB
IMU Acquisition of immuno-oncology technologyPRICE SENSITIVE13/12/16 download Created with Sketch. 83.3KB
IMU Response to ASX Price QueryPRICE SENSITIVE25/11/16 download Created with Sketch. 172.93KB
IMU Leslie Chong Appointed Chief Executive OfficerPRICE SENSITIVE21/11/16 download Created with Sketch. 174.4KB
IMU Imugene Commences HER-Vaxx Phase 1b/2 Gastric Cancer StudyPRICE SENSITIVE07/11/16 download Created with Sketch. 179.34KB
IMU Appendix 4C - quarterly-IMU.AX PRICE SENSITIVE27/10/16 download Created with Sketch. 296.35KB
IMU Imugene Share Placement raises $3.2 million-IMU.AX PRICE SENSITIVE21/10/16 download Created with Sketch. 170.52KB
IMU Trading Halt-IMU.AX PRICE SENSITIVE19/10/16 download Created with Sketch. 268.86KB
IMU Imugene receives $1.3m R&D Tax Refund-IMU.AX PRICE SENSITIVE22/09/16 download Created with Sketch. 152.62KB
IMU Imugene successfully completes preclinical animal studies-IMU.AX PRICE SENSITIVE20/09/16 download Created with Sketch. 56.94KB
IMU Preliminary Final Report-IMU.AX PRICE SENSITIVE30/08/16 download Created with Sketch. 123.14KB
IMU Imugene Final Cancer Vaccine Doses Delivered to GMP Depot-IMU.AX PRICE SENSITIVE30/08/16 download Created with Sketch. 61.47KB
IMU Imugene Receives Approval to Start Gastric Cancer Study-IMU.AX PRICE SENSITIVE22/08/16 download Created with Sketch. 173.4KB
IMU Imugene Receives Institutional Review Board approval-IMU.AX PRICE SENSITIVE11/08/16 download Created with Sketch. 44.54KB
IMU Appendix 4C - quarterly-IMU.AX PRICE SENSITIVE29/07/16 download Created with Sketch. 392.39KB
IMU Imugene Receives Institutional Review Board Approval-IMU.AX PRICE SENSITIVE11/07/16 download Created with Sketch. 268.17KB
IMU Appendix 4C - quarterly-IMU.AX PRICE SENSITIVE29/04/16 download Created with Sketch. 689.56KB
IMU Regulatory package submission for Her-Vaxx in Hong Kong-IMU.AX PRICE SENSITIVE21/04/16 download Created with Sketch. 140.36KB
IMU Manufacturing UpdatePRICE SENSITIVE07/03/16 download Created with Sketch. 50.79KB
IMU Half Yearly Report and AccountsPRICE SENSITIVE29/02/16 download Created with Sketch. 695.7KB
IMU Appendix 4C - quarterlyPRICE SENSITIVE27/01/16 download Created with Sketch. 153.95KB
IMU Partnership to Develop Mimotope Immuno-Oncology PlatformPRICE SENSITIVE20/01/16 download Created with Sketch. 56.12KB
IMU Imugene key HER-Vaxx patent granted in EuropePRICE SENSITIVE18/12/15 download Created with Sketch. 45.22KB
IMU Novotech appointed Contract Research OrganisationPRICE SENSITIVE14/12/15 download Created with Sketch. 48.37KB
IMU Appendix 4C - quarterlyPRICE SENSITIVE28/10/15 download Created with Sketch. 143.97KB
IMU Imugene Receives $755k R&D Tax RefundPRICE SENSITIVE28/10/15 download Created with Sketch. 116.37KB
IMU Prospectus for Placement & Loyalty OptionsPRICE SENSITIVE23/10/15 download Created with Sketch. 2.45MB
IMU Imugene announces bonus options issuePRICE SENSITIVE13/10/15 download Created with Sketch. 40.75KB
IMU Imugene Announces Successful Capital RaisingPRICE SENSITIVE08/09/15 download Created with Sketch. 71.52KB
IMU Trading HaltPRICE SENSITIVE07/09/15 download Created with Sketch. 326.63KB
IMU Appendix 4E and Annual Report 2015PRICE SENSITIVE31/08/15 download Created with Sketch. 1.57MB
IMU Appendix 4C - quarterlyPRICE SENSITIVE30/07/15 download Created with Sketch. 152.1KB
IMU CRO Appointed to Conduct Phase 1b/2 Gastric Cancer TrialPRICE SENSITIVE01/07/15 download Created with Sketch. 106.09KB
IMU HER-Vaxx superior to Herceptin in tumour modelPRICE SENSITIVE22/05/15 download Created with Sketch. 570.55KB
IMU Appendix 4C - quarterlyPRICE SENSITIVE29/04/15 download Created with Sketch. 152.22KB
IMU Imugene Files New HER-Vaxx PatentPRICE SENSITIVE21/04/15 download Created with Sketch. 62.06KB
IMU HER-Vaxx Re-Formulation Increases Efficacy Ten-FoldPRICE SENSITIVE20/04/15 download Created with Sketch. 75.2KB
IMU Appendix 4D - Half Yearly Report and AccountsPRICE SENSITIVE27/02/15 download Created with Sketch. 809.86KB
IMU Response to Price QueryPRICE SENSITIVE20/02/15 download Created with Sketch. 216.08KB
IMU Imugene Receives $230K Research and Development Tax RefundPRICE SENSITIVE18/02/15 download Created with Sketch. 57.21KB
IMU Appointment of Charles Walker as Managing DirectorPRICE SENSITIVE02/02/15 download Created with Sketch. 51.96KB
IMU Appendix 4C - quarterlyPRICE SENSITIVE28/01/15 download Created with Sketch. 152.73KB
IMU New milestones in preparation for HER-Vaxx clinical trialPRICE SENSITIVE30/12/14 download Created with Sketch. 68.18KB
IMU Further placement & close of SPP raising over $3.5m in totalPRICE SENSITIVE09/12/14 download Created with Sketch. 65.49KB
IMU HER-Vaxx peptides demonstrate high level of activityPRICE SENSITIVE01/12/14 download Created with Sketch. 73.12KB
IMU Imugene to divest Linguet drug delivery technologyPRICE SENSITIVE28/11/14 download Created with Sketch. 64.48KB
IMU Appendix 4C - Quarterly and Business Update
16/04/19PRICE SENSITIVE download Created with Sketch. 270.77KB
IMU IMU presents new mimotope PD-1 vaccine data at AACR
03/04/19PRICE SENSITIVE download Created with Sketch. 160.49KB
IMU IMU presents new KEY-Vaxx and B-Vaxx data at AACR
02/04/19PRICE SENSITIVE download Created with Sketch. 164.88KB
IMU IMU presents positive new HER-Vaxx data at AACR
02/04/19PRICE SENSITIVE download Created with Sketch. 167.49KB
IMU IMU Pre-IND FDA Meeting Provides Guidance for KEY-Vaxx
20/03/19PRICE SENSITIVE download Created with Sketch. 75.86KB
IMU Imugene doses first patient in HER-Vaxx phase 2 trial
14/03/19PRICE SENSITIVE download Created with Sketch. 96.99KB
IMU IMU Announces Presentations on KEY-Vaxx and B-Vaxx at AACR
04/03/19PRICE SENSITIVE download Created with Sketch. 100.39KB
IMU Half Yearly Report and Accounts
28/02/19PRICE SENSITIVE download Created with Sketch. 4.58MB
IMU Pause in Trading
28/02/19PRICE SENSITIVE download Created with Sketch. 116KB
IMU Imugene Announces Presentation on HER-Vaxx at the AACR 2019
28/02/19PRICE SENSITIVE download Created with Sketch. 85.19KB
IMU Appendix 4C - Quarterly and Business Update
30/01/19PRICE SENSITIVE download Created with Sketch. 557.58KB
IMU Investor Presentation
10/01/19PRICE SENSITIVE download Created with Sketch. 11.83MB
IMU IMU Meets Endpoints in Phase 1b Gastric Cancer Trial
17/12/18PRICE SENSITIVE download Created with Sketch. 114.47KB
IMU Imugene Advances to Phase 2 in Gastric Cancer Trial
13/11/18PRICE SENSITIVE download Created with Sketch. 366.09KB
IMU Imugene Receives $1.85 million R&D Tax Incentive
09/11/18PRICE SENSITIVE download Created with Sketch. 101.15KB
IMU Appendix 4C - quarterly
30/10/18PRICE SENSITIVE download Created with Sketch. 1.05MB
IMU Imugene commences cGMP manufacture of PD-1 cancer vaccine
21/09/18PRICE SENSITIVE download Created with Sketch. 141.95KB
IMU Imugene Completes Phase 1b Cancer Vaccine Trial Recruitment
11/09/18PRICE SENSITIVE download Created with Sketch. 393.79KB
IMU Appendix 4E and Audited Financial Report
31/08/18PRICE SENSITIVE download Created with Sketch. 539.83KB
IMU Appendix 4C - Quarterly and Business Update
31/07/18PRICE SENSITIVE download Created with Sketch. 555.82KB
IMU PD-1 cancer vaccine development update
23/07/18PRICE SENSITIVE download Created with Sketch. 399.17KB
IMU Response to ASX Query
08/06/18PRICE SENSITIVE download Created with Sketch. 496.2KB
IMU Prospectus
07/06/18PRICE SENSITIVE download Created with Sketch. 976.05KB
IMU IMUGENE RAISES $20.1 MILLION
07/06/18PRICE SENSITIVE download Created with Sketch. 584.16KB
IMU Imugene Licences Extensive B-Cell Immuno-Oncology Portfolio
07/06/18PRICE SENSITIVE download Created with Sketch. 341.69KB
IMU Trading Halt
05/06/18PRICE SENSITIVE download Created with Sketch. 443.43KB
IMU Appendix 4C - quarterly
26/04/18PRICE SENSITIVE download Created with Sketch. 658.65KB
IMU Leslie Chong Appointed as Managing Director
28/03/18PRICE SENSITIVE download Created with Sketch. 223.16KB
IMU Half Yearly Report and Accounts
27/02/18PRICE SENSITIVE download Created with Sketch. 273.35KB
IMU Arginine Modulator Active in Cancer Models
19/02/18PRICE SENSITIVE download Created with Sketch. 242.78KB
IMU Novel Anti-PD-1 Mimotope Vaccine Ready for Development
12/02/18PRICE SENSITIVE download Created with Sketch. 167.45KB
IMU IMU Meets Investigator for Gastric Cancer Clinical Trial
09/02/18PRICE SENSITIVE download Created with Sketch. 45.28KB
IMU Cancer vaccine shows early promise in clinical trial
07/02/18PRICE SENSITIVE download Created with Sketch. 238.61KB
IMU Business Update - December Quarter Appendix 4C
29/01/18PRICE SENSITIVE download Created with Sketch. 986.49KB
IMU Rights Issue Results & Shortfall Notification
19/12/17PRICE SENSITIVE download Created with Sketch. 37.68KB
IMU Prospectus
23/11/17PRICE SENSITIVE download Created with Sketch. 946.63KB
IMU IMUGENE RAISES $8.7 MILLION
23/11/17PRICE SENSITIVE download Created with Sketch. 72.07KB
IMU Trading Halt
21/11/17PRICE SENSITIVE download Created with Sketch. 264.26KB
IMU Appendix 4C - Quarterly and Business Update
27/10/17PRICE SENSITIVE download Created with Sketch. 990.52KB
IMU Response to ASX Price Query
17/10/17PRICE SENSITIVE download Created with Sketch. 609.6KB
IMU IMU Receives $1.1m R&D Tax Refund
11/10/17PRICE SENSITIVE download Created with Sketch. 296.02KB
IMU First Patient Dosing Commences of HER-Vaxx
31/08/17PRICE SENSITIVE download Created with Sketch. 53.78KB
IMU Appendix 4E and Annual Report
31/08/17PRICE SENSITIVE download Created with Sketch. 642.26KB
IMU Appendix 4C - quarterly
31/07/17PRICE SENSITIVE download Created with Sketch. 984.1KB
IMU Imugene granted Canadian patent for Her-Vaxx cancer vaccine
21/07/17PRICE SENSITIVE download Created with Sketch. 42.21KB
IMU Appendix 4C - quarterly and Commentry Q3
28/04/17PRICE SENSITIVE download Created with Sketch. 856.23KB
IMU IMU Raises $3.0m from Options Plan
06/04/17PRICE SENSITIVE download Created with Sketch. 33.34KB
IMU $1.35 million Options Underwritten
30/03/17PRICE SENSITIVE download Created with Sketch. 66.21KB
IMU Half Year Report and Accounts
28/02/17PRICE SENSITIVE download Created with Sketch. 219.56KB
IMU Intellectual Property Strengthened Around Lead Clinical Drug
27/02/17PRICE SENSITIVE download Created with Sketch. 247.31KB
IMU BMC Cancer journal publishes encouraging HER-Vaxx research
13/02/17PRICE SENSITIVE download Created with Sketch. 243.06KB
IMU Appendix 4C - quarterly
27/01/17PRICE SENSITIVE download Created with Sketch. 295.18KB
IMU Imugene progresses mimotope platform
19/12/16PRICE SENSITIVE download Created with Sketch. 239.63KB
IMU Response to ASX Aware Query
16/12/16PRICE SENSITIVE download Created with Sketch. 202.23KB
IMU Response to ASX Price Query
13/12/16PRICE SENSITIVE download Created with Sketch. 412.71KB
IMU Acquisition of immuno-oncology technology
13/12/16PRICE SENSITIVE download Created with Sketch. 83.3KB
IMU Response to ASX Price Query
25/11/16PRICE SENSITIVE download Created with Sketch. 172.93KB
IMU Leslie Chong Appointed Chief Executive Officer
21/11/16PRICE SENSITIVE download Created with Sketch. 174.4KB
IMU Imugene Commences HER-Vaxx Phase 1b/2 Gastric Cancer Study
07/11/16PRICE SENSITIVE download Created with Sketch. 179.34KB
IMU Appendix 4C - quarterly-IMU.AX
27/10/16PRICE SENSITIVE download Created with Sketch. 296.35KB
IMU Imugene Share Placement raises $3.2 million-IMU.AX
21/10/16PRICE SENSITIVE download Created with Sketch. 170.52KB
IMU Trading Halt-IMU.AX
19/10/16PRICE SENSITIVE download Created with Sketch. 268.86KB
IMU Imugene receives $1.3m R&D Tax Refund-IMU.AX
22/09/16PRICE SENSITIVE download Created with Sketch. 152.62KB
IMU Imugene successfully completes preclinical animal studies-IMU.AX
20/09/16PRICE SENSITIVE download Created with Sketch. 56.94KB
IMU Preliminary Final Report-IMU.AX
30/08/16PRICE SENSITIVE download Created with Sketch. 123.14KB
IMU Imugene Final Cancer Vaccine Doses Delivered to GMP Depot-IMU.AX
30/08/16PRICE SENSITIVE download Created with Sketch. 61.47KB
IMU Imugene Receives Approval to Start Gastric Cancer Study-IMU.AX
22/08/16PRICE SENSITIVE download Created with Sketch. 173.4KB
IMU Imugene Receives Institutional Review Board approval-IMU.AX
11/08/16PRICE SENSITIVE download Created with Sketch. 44.54KB
IMU Appendix 4C - quarterly-IMU.AX
29/07/16PRICE SENSITIVE download Created with Sketch. 392.39KB
IMU Imugene Receives Institutional Review Board Approval-IMU.AX
11/07/16PRICE SENSITIVE download Created with Sketch. 268.17KB
IMU Appendix 4C - quarterly-IMU.AX
29/04/16PRICE SENSITIVE download Created with Sketch. 689.56KB
IMU Regulatory package submission for Her-Vaxx in Hong Kong-IMU.AX
21/04/16PRICE SENSITIVE download Created with Sketch. 140.36KB
IMU Manufacturing Update
07/03/16PRICE SENSITIVE download Created with Sketch. 50.79KB
IMU Half Yearly Report and Accounts
29/02/16PRICE SENSITIVE download Created with Sketch. 695.7KB
IMU Appendix 4C - quarterly
27/01/16PRICE SENSITIVE download Created with Sketch. 153.95KB
IMU Partnership to Develop Mimotope Immuno-Oncology Platform
20/01/16PRICE SENSITIVE download Created with Sketch. 56.12KB
IMU Imugene key HER-Vaxx patent granted in Europe
18/12/15PRICE SENSITIVE download Created with Sketch. 45.22KB
IMU Novotech appointed Contract Research Organisation
14/12/15PRICE SENSITIVE download Created with Sketch. 48.37KB
IMU Appendix 4C - quarterly
28/10/15PRICE SENSITIVE download Created with Sketch. 143.97KB
IMU Imugene Receives $755k R&D Tax Refund
28/10/15PRICE SENSITIVE download Created with Sketch. 116.37KB
IMU Prospectus for Placement & Loyalty Options
23/10/15PRICE SENSITIVE download Created with Sketch. 2.45MB
IMU Imugene announces bonus options issue
13/10/15PRICE SENSITIVE download Created with Sketch. 40.75KB
IMU Imugene Announces Successful Capital Raising
08/09/15PRICE SENSITIVE download Created with Sketch. 71.52KB
IMU Trading Halt
07/09/15PRICE SENSITIVE download Created with Sketch. 326.63KB
IMU Appendix 4E and Annual Report 2015
31/08/15PRICE SENSITIVE download Created with Sketch. 1.57MB
IMU Appendix 4C - quarterly
30/07/15PRICE SENSITIVE download Created with Sketch. 152.1KB
IMU CRO Appointed to Conduct Phase 1b/2 Gastric Cancer Trial
01/07/15PRICE SENSITIVE download Created with Sketch. 106.09KB
IMU HER-Vaxx superior to Herceptin in tumour model
22/05/15PRICE SENSITIVE download Created with Sketch. 570.55KB
IMU Appendix 4C - quarterly
29/04/15PRICE SENSITIVE download Created with Sketch. 152.22KB
IMU Imugene Files New HER-Vaxx Patent
21/04/15PRICE SENSITIVE download Created with Sketch. 62.06KB
IMU HER-Vaxx Re-Formulation Increases Efficacy Ten-Fold
20/04/15PRICE SENSITIVE download Created with Sketch. 75.2KB
IMU Appendix 4D - Half Yearly Report and Accounts
27/02/15PRICE SENSITIVE download Created with Sketch. 809.86KB
IMU Response to Price Query
20/02/15PRICE SENSITIVE download Created with Sketch. 216.08KB
IMU Imugene Receives $230K Research and Development Tax Refund
18/02/15PRICE SENSITIVE download Created with Sketch. 57.21KB
IMU Appointment of Charles Walker as Managing Director
02/02/15PRICE SENSITIVE download Created with Sketch. 51.96KB
IMU Appendix 4C - quarterly
28/01/15PRICE SENSITIVE download Created with Sketch. 152.73KB
IMU New milestones in preparation for HER-Vaxx clinical trial
30/12/14PRICE SENSITIVE download Created with Sketch. 68.18KB
IMU Further placement & close of SPP raising over $3.5m in total
09/12/14PRICE SENSITIVE download Created with Sketch. 65.49KB
IMU HER-Vaxx peptides demonstrate high level of activity
01/12/14PRICE SENSITIVE download Created with Sketch. 73.12KB
IMU Imugene to divest Linguet drug delivery technology
28/11/14PRICE SENSITIVE download Created with Sketch. 64.48KB
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist
(20min delay)
Last
26.8¢
Change
0.003(0.94%)
Mkt cap ! $77.17M
Open High Low Value Volume
26.5¢ 27.0¢ 25.5¢ $449.3K 1.715M

Buyers (Bids)

No. Vol. Price($)
11 259871 26.5¢
 

Sellers (Offers)

Price($) Vol. No.
27.0¢ 132917 21
View Market Depth
Last trade - 13.25pm 11/08/2025 (20 minute delay) ?
Last
26.5¢
  Change
0.003 ( 0.11 %)
Open High Low Volume
26.0¢ 26.5¢ 25.5¢ 355761
Last updated 13.44pm 11/08/2025 ?
IMU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.